Tresrich Mf Solution contains Minoxidil. Tresrich Mf Solution uses:
Tresrich Mf Solution is indicated in the treatment of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia, and also of alopecia areata.
|Brand Name:||Tresrich Mf Solution|
|Therapeutic Class:||Other scalp preparations|
|Manufacturer:||SKINSKA PHARMACEUTICALS PVT LTD|
|Last Updated:||2020-11-21 18:15:00|
Tresrich Mf Solution contains Minoxidil 5.0 %. Tresrich Mf Solution doses
Tresrich Mf Solution topical solution is for external use only and should be applied when the hair and scalp are clean and dry. Apply 1 ml (7 sprays) of Tresrich Mf Solution topical solution twice daily at 12-hour intervals to the scalp, beginning at the centre of the affected area and spreading the solution out to cover the entire affected area. The total daily application dose should not exceed 2 ml.
For the best results, Tresrich Mf Solution topical solution should be allowed to remain on the scalp for about 4 hours before washing. The night-time application should be done 2-4 hours before going to bed to allow the solution to dry out. Tresrich Mf Solution topical solution should not be massaged into the scalp, but applied lightly. A hair dryer should not be used to speed up the drying of the solution as it may decrease the effectiveness. Tresrich Mf Solution topical solution should not be mixed with any hair oil. The drug should not be used more than two times a day, or be taken orally or applied to any other part of the body to avoid the risk of adverse effects and unwanted hair growth. More frequent use or longer application time have no effect on hair growth. In case of missing any daily applications of Tresrich Mf Solution topical solution, the patient should continue with the next application.
Hands should be washed immediately if Tresrich Mf Solution topical solution is applied with the fingertips. Clinical experience with Tresrich Mf Solution indicates that twice-daily applications for 4 months or more may be required before there is evidence of hair growth. To arrest hair fall, Tresrich Mf Solution topical solution should be used for not less than 45 days. Depending upon the severity of hair loss or type and extent of baldness, particular strength of Tresrich Mf Solution topical solution may be selected.
Commonly encountered side effects in clinical trials with Tresrich Mf Solution topical solution were minor dermatological reactions. Dermatitis or hypertrichosis may occur. These incidences may occur in 0.1–5% of patients.
Tresrich Mf Solution stimulates hair growth by increasing oxygen, blood and nutrients supply to the hair follicle by widening blood vessels and inhibiting androgen hormone to affect hair follicles.
Following topical application, an average of about 1.4% of the total applied dose is absorbed from the normal intact scalp. Topical Tresrich Mf Solution absorption is increased by increasing the dose applied, increasing the frequency of dosing and decreasing the barrier function of the stratum corneum. Serum Tresrich Mf Solution levels and systemic effects resulting from the administration of topical Tresrich Mf Solution are governed by the drug’s absorption rate through the skin. Following cessation of topical dosing, approximately 95% of the systemically absorbed drug is eliminated within 4 days. Tresrich Mf Solution and its metabolites are excreted principally in the urine.
Tresrich Mf Solution topical solution is more likely to cause scalp irritation. If scalp irritation continues or worsen, use of Tresrich Mf Solution topical solution should be stopped.
Tresrich Mf Solution topical solution should not be used along with other topical agents known to alter the stratum corneum barrier such as tretinoin or dithranol, due to the enhanced absorption of Tresrich Mf Solution. Although there is no clinical evidence, there exists the theoretical possibility of absorbed Tresrich Mf Solution potentiating orthostatic hypotension caused by peripheral vasodilators.
Tresrich Mf Solution topical solution should not be used during pregnancy and lactation.
Increased systemic absorption of Tresrich Mf Solution may potentially occur if higher-than-recommended doses of Tresrich Mf Solution are applied to larger surface areas of the body or areas other than the scalp. There are no known cases of Tresrich Mf Solution overdosage resulting from topical administration of Tresrich Mf Solution.
Signs and symptoms of Tresrich Mf Solution overdosage would primarily be cardiovascular effects associated with sodium and water retention, and tachycardia. Fluid retention can be managed with appropriate diuretic therapy. Clinically significant tachycardia can be controlled by administration of a beta-adrenergic blocking agent.
Store at a cool and dry place, protected from light. Keep out of the reach of the children.
Tresrich Mf Solution price in India 585.65